Ascus Biosciences
Ascus Biosciences, a San Diego-based firm, pioneers in developing next-gen microbial products since 2015.
Founded
2015Ascus Biosciences, a San Diego-based firm, pioneers in developing next-gen microbial products since 2015.
Ascus Biosciences, founded in 2015 and headquartered in San Diego, California, specializes in developing next-generation microbial products using computational and genomics-based technology. The company's core mission is to revolutionize animal health and nutrition through innovative feed additives. By leveraging advanced scientific methods, Ascus aims to create sustainable and effective solutions for the agricultural industry, focusing on enhancing the health and productivity of livestock.
Notable figures associated with Ascus Biosciences include its team of experienced scientists and industry experts who drive its research and development efforts. The company has attracted significant investment from venture capital firms specializing in biotech innovations. Key achievements include the successful commercialization of several microbial feed additives that have demonstrated substantial improvements in animal health and farm productivity. Ascus Biosciences continues to make a significant impact on the agricultural sector by promoting sustainable practices and advancing animal nutrition technology.
Companies similar to Ascus Biosciences include AsimicA, Native Microbials, Ascribe Bioscience and Akeso Biomedical.
Ascus Biosciences was founded in 2015.
Ascus Biosciences' headquarters is located in San Diego, CA, US.
Ascus Biosciences' most recent funding round was for $46M (USD) in May 2020.
As of May 27, 2020, Ascus Biosciences has disclosed funding of $51M (USD). Undisclosed round amounts are excluded.
Ascus Biosciences has 30 employees as of Feb 5, 2024.
Akeso Biomedical
